FdaApplication
ANDA 212816
Identifiers
- fda_app_no: ANDA212816
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2023-07-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 20MEQ | FOR SOLUTION;ORAL |
1 product